LC
TMO icon

Lindbrook Capital’s Thermo Fisher Scientific TMO Stock Holding History

Lindbrook Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$4.01M Buy
8,063
+345
+4% +$187K 0.37% 45
2024
Q4 		$4.02M Sell
7,718
-91
-1% -$50K 0.36% 41
2024
Q3 		$4.83M Sell
7,809
-352
-4% -$208K 0.43% 36
2024
Q2 		$4.51M Sell
8,161
-1,130
-12% -$647K 0.42% 37
2024
Q1 		$5.4M Buy
9,291
+126
+1% +$70.7K 0.51% 36
2023
Q4 		$4.86M Buy
9,165
+130
+1% +$62.9K 0.49% 39
2023
Q3 		$4.57M Buy
9,035
+199
+2% +$106K 0.51% 34
2023
Q2 		$4.61M Buy
8,836
+214
+2% +$115K 0.49% 36
2023
Q1 		$4.97M Buy
8,622
+238
+3% +$134K 0.58% 28
2022
Q4 		$4.62M Buy
8,384
+7,473
+820% +$3.96M 0.57% 27
2022
Q3 		$462K Buy
911
+106
+13% +$59.3K 0.08% 154
2022
Q2 		$437K Buy
805
+28
+4% +$15.4K 0.07% 167
2022
Q1 		$459K Sell
777
-29
-4% -$16.7K 0.07% 172
2021
Q4 		$538K Buy
806
+206
+34% +$129K 0.08% 153
2021
Q3 		$343K Buy
600
+16
+3% +$8.78K 0.09% 94
2021
Q2 		$295K Buy
584
+16
+3% +$7.55K 0.07% 126
2021
Q1 		$259K Buy
568
+30
+6% +$14.3K 0.06% 132
2020
Q4 		$251K Sell
538
-14
-3% -$6.56K 0.06% 121
2020
Q3 		$244K Sell
552
-11
-2% -$4.54K 0.07% 109
2020
Q2 		$204K Sell
563
-11
-2% -$3.69K 0.06% 121
2020
Q1 		$163K Sell
574
-145
-20% -$45.7K 0.06% 122
2019
Q4 		$234K Buy
719
+22
+3% +$6.67K 0.08% 121
2019
Q3 		$203K Sell
697
-14
-2% -$4.01K 0.08% 132
2019
Q2 		$208K Buy
711
+13
+2% +$3.58K 0.08% 129
2019
Q1 		$191K Buy
698
+120
+21% +$29.9K 0.08% 136
2018
Q4 		$129K Buy
+578
New +$136K 0.06% 159

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Lindbrook Capital's TMO Position: Q1 2025 in Review

Lindbrook Capital increased its Thermo Fisher Scientific (TMO) stake by 4.5% in Q1 2025, buying an estimated $187K and bringing the position to 8,063 shares worth $4.01M. The position accounts for 0.37% of the portfolio, ranked #45.

Lindbrook Capital first reported a position in TMO in Q4 2018 and has held it in 26 quarters since. The position peaked at $5.4M in Q1 2024. 2,572 funds tracked by Wall St. Rank hold TMO as of Q1 2025.

  • Lindbrook Capital held 8,063 shares of Thermo Fisher Scientific worth $4.01M as of Q1 2025.
  • Lindbrook Capital bought 345 Thermo Fisher Scientific shares in Q1 2025, an estimated $187K.
  • Thermo Fisher Scientific made up 0.37% of Lindbrook Capital's portfolio in Q1 2025, its #45 holding.
  • Lindbrook Capital first reported a position in Thermo Fisher Scientific in Q4 2018 and has held it in 26 quarters since.
  • Lindbrook Capital's Thermo Fisher Scientific position peaked at $5.4M in Q1 2024.
  • 2,572 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.